Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Unresectable Pleural Mesothelioma: later-stage trial registry

1 of 1 indexed Unresectable Pleural Mesothelioma trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Unresectable Pleural Mesothelioma: 1 US clinical trial tracked, 1 recruiting.

Unresectable Pleural Mesothelioma is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is AstraZeneca, running 1 of these trials.

Enrollment posture brief

Registry condition unresectable-pleural-mesothelioma

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Unresectable Pleural Mes (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Unresectable Pleural Mesothelioma

Unresectable Pleural Mesothelioma lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Unresectable Pleural Mesothelioma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Unresectable Pleural Mesothelioma is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

AstraZeneca 1 trials

Named interventions

Most-linked intervention names on Unresectable Pleural Mesothelioma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Volrustomig Drug
1 trials
Nivolumab Drug
1 trials
Pemetrexed Drug
1 trials
Cisplatin Drug
1 trials
Carboplatin Drug
1 trials

US sites by state

Facility locations filed on Unresectable Pleural Mesothelioma trials. A trial with sites in several states counts in each.

Oregon 1 trials
Ohio 1 trials
New York 1 trials
New Jersey 1 trials
Missouri 1 trials
Minnesota 1 trials
Maryland 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Unresectable Pleural Mesothelioma page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Unresectable Pleural Mesothelioma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • AstraZeneca sponsors the most Unresectable Pleural Mesothelioma trials on record, review their full trial history before evaluating a specific study. See AstraZeneca's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Unresectable Pleural Mesothelioma condition card totals 1 registered trials; most-linked intervention Volrustomig; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.